MEDIAN TECHNOLOGIES (EPA:ALMDT) | Finanzwire

Basculer en Français

9472	Companies
185369	Keywords
117719	Articles
99261	Press releases

Home
Companies
MEDIAN TECHNOLOGIES

BRIEF

published on 12/03/2025 at 17:50, 1 day 12 hours ago

Median Technologies Reveals Voting Rights and Share Capital Structure

Share Capital Voting Rights Regulatory Compliance Financial Transparency Median Technologies
PRESS RELEASE

published on 12/03/2025 at 17:45, 1 day 12 hours ago

Total number of voting rights and capital / Information on the total number of voting rights and the number of shares making up the capital
Median Technologies discloses total voting rights & shares as of Nov 30, 2025, in compliance with French regulations. Company pioneers AI for cancer diagnosis & treatment

Voting Rights Shares French Regulations Median Technologies Cancer Diagnosis
BRIEF

published on 10/21/2025 at 17:50, 1 month 14 days ago

Median Technologies receives €19 million in financing from the EIB

Funding European Investment Bank Median Technologies Cancer Diagnosis Eyonis® LCS
BRIEF

published on 10/13/2025 at 17:50, 1 month 22 days ago

Median Technologies: Documents available for the AGM of October 31, 2025

Shareholders Paris General Assembly Preparatory Documents Median Technologies
BRIEF

published on 08/07/2025 at 17:50, 3 months 28 days ago

MEDIAN TECHNOLOGIES: Voting Rights and Share Capital Update

Share Capital Voting Rights French Regulations Treasury Shares Median Technologies
PRESS RELEASE

published on 08/07/2025 at 17:45, 3 months 28 days ago

Total number of voting rights and capital / Information on the total number of voting rights and the number of shares making up the capital
Median Technologies discloses total voting rights and shares as of July 31, 2025, per French regulations. The company pioneers AI-driven medical software for cancer diagnosis and treatment

Voting Rights Shares Median Technologies Cancer Diagnosis AI-driven Software
BRIEF

published on 07/11/2025 at 18:51, 4 months 24 days ago

Median Technologies Secures €37.5 Million Financing with EIB

Financing Facility European Investment Bank Median Technologies Cancer Diagnosis Eyonis® LCS
PRESS RELEASE

published on 07/11/2025 at 18:46, 4 months 24 days ago

Inside Information / Other news releases
Median Technologies signs €37.5M financing facility with EIB to support eyonis® AI-powered Software as a Medical Device for cancer diagnosis. Financial independence strengthened for US and EU commercialization

Financial Agreement Median Technologies Cancer Diagnosis EIB Financing Eyonis AI
BRIEF

published on 07/09/2025 at 17:50, 4 months 26 days ago

Median Technologies Reports Mid-Year Liquidity Contract Status

Liquidity Contract Transactions Shares Median Technologies Financial Account
PRESS RELEASE

published on 07/09/2025 at 17:45, 4 months 26 days ago

Acquisition or disposal of the issuer's own shares / Information relating to the liquidity contract
Median Technologies reports half-year liquidity contract details with TP ICAP. 60,808 shares and €58,893.66 cash as of June 30, 2025. 469 buy and 395 sell transactions in the first half of 2025

Liquidity Contract Transactions Shares TP ICAP Median Technologies

1 2 ... 4

Accesswire

Published on 12/05/2025 at 02:35, 3 hours 20 minutes ago

Future Fuels Initates Drill Permitting at Hornby; Marketing Update
Published on 12/05/2025 at 02:30, 3 hours 25 minutes ago

Klondike Gold Announces AGM Results
Published on 12/05/2025 at 01:00, 4 hours 55 minutes ago

BEACN Closes First Tranche of Non-Brokered Private Placement
Published on 12/04/2025 at 23:05, 6 hours 50 minutes ago

BlackBerry to Announce Third Quarter Fiscal Year 2026 Results on December 18, 2025
Published on 12/04/2025 at 23:00, 6 hours 55 minutes ago

NXT Energy Solutions Completes Data Acquisition for SFD Survey

View all ACCESSWIRE

EQS Group

Published on 12/05/2025 at 03:30, 2 hours 25 minutes ago

CGTN: What makes cooperation between China and France a two-way success
Published on 12/04/2025 at 23:50, 6 hours 4 minutes ago

EQS-Adhoc: Dexus Finance Pty Limited: Dexus prices A$500 million of subordinated notes
Published on 12/04/2025 at 20:25, 9 hours 30 minutes ago

Newmark Appoints Globally Recognized Real Estate Executive Peter Trollope to Lead Occupier Solutions
Published on 12/04/2025 at 20:15, 9 hours 40 minutes ago

Galimedix Therapeutics presents compelling Phase 1 study results showing excellent safety and pharmacokinetics with oral small molecule GAL-101 at CTAD 2025
Published on 12/04/2025 at 19:10, 10 hours 44 minutes ago

SCHOTT Pharma’s preliminary results for fiscal year 2025; outlook for FY 2026 and update of mid-term guidance

Les Echos

Published on 12/04/2025 at 18:00, 11 hours 55 minutes ago

Information concerning the total number of voting rights and shares in the share capital as of November 28, 2025
Published on 12/04/2025 at 17:45, 12 hours 10 minutes ago

MONTHLY INFORMATION RELATING TO THE TOTAL NUMBER OF VOTING RIGHTS AND SHARES MAKING UP THE SHARE CAPITAL
Published on 12/04/2025 at 17:44, 12 hours 11 minutes ago

Net profit attributable to owners of the parent up by 63% to €122 million, driven by business resilience and the improvement in Elior's contribution
Published on 12/04/2025 at 07:01, 22 hours 54 minutes ago

bioMérieux launches leading endocrinology testing offer dedicated to enhancing equine health
Published on 12/03/2025 at 18:00, 1 day 11 hours ago

Declaration of voting rights at the end of November 2025

View all LES ECHOS COMFI WIRE